Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2026 · 10-Q
Revenue$321.39M$321.39M−4.4% vs Q1 2025 Net Income$34.03M$34.03M−11.3% vs Q1 2025 EPS Diluted$0.70$0.70−5.4% vs Q1 2025 Gross Profit$192,244,000+9.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$17,395,000N/M Free Cash Flowderived$13,641,000N/M Margins · derivedGross margin59.8%+7.8 pt vs Q1 2025
Operating margin16.8%+4.9 pt vs Q1 2025
Net margin10.6%−0.8 pt vs Q1 2025
ended Jun 28, 2025 · filed Aug 7, 2025 · 40 d after period end